Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Agnese Cangini"'
Autor:
Alessandro Petrella, Filomena Fortinguerra, Agnese Cangini, Andrea Pierantozzi, Francesco Trotta
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
BackgroundMany countries use the WHO Essential Medicines List (EML) as a guide for health policy choices to promote the efficient use of healthcare resources or adopt the concept of essential medicines (EMs) to develop their own national list of esse
Externí odkaz:
https://doaj.org/article/8e56b4bce77549a6bc0f195f3bac2ce7
Autor:
Serena Perna, Agnese Cangini, Roberto Marini, Maria Alessandra Guerrizio, Roberto Da Cas, Giuseppe Traversa, Francesco Trotta
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
IntroductionThe aim of the study was to evaluate, in a regulated generics market, the effect of the number of manufacturers of generic drugs on the amplitude of off-patent products price reduction and the price evolution of originators and generics a
Externí odkaz:
https://doaj.org/article/382849c6c4e04349b167dacb56539844
Autor:
Claudio Jommi, Elisabetta Listorti, Federico Villa, Simone Ghislandi, Armando Genazzani, Agnese Cangini, Francesco Trotta
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-10 (2021)
Abstract Background and aim Evidence on determinants of prices for orphan medicines is scarce and not available for Italy. The aim of this paper is to provide an evidence on variables affecting the annual treatment cost of orphan drugs in Italy, test
Externí odkaz:
https://doaj.org/article/3b1356b07d8a4883a3a451e4cc588b24
Autor:
Maria Beatrice Zazzara, Agnese Cangini, Roberto Da Cas, Ilaria Ippoliti, Alessandra Marengoni, Andrea Pierantozzi, Elisabetta Poluzzi, Simona Zito, Graziano Onder, the Italian Working Group on Medication Use in the Elderly
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Older adults are often affected by multiple chronic conditions and experience geriatric syndromes that may affect the risk/benefit profile of medications. Little is known about the use of such medications in the older population. This article describ
Externí odkaz:
https://doaj.org/article/c146c1cd08f54972a18b8a8f08a715d4
Autor:
Federico Villa, Aurora Di Filippo, Andrea Pierantozzi, Armando Genazzani, Antonio Addis, Gianluca Trifirò, Agnese Cangini, Giovanni Tafuri, Daniela Settesoldi, Francesco Trotta
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
IntroductionIt is well acknowledged that the price of orphan drugs is normally higher than that resulting from the value-based pricing. A correlation between the cost of therapy for orphan drugs and the epidemiology (prevalence and incidence) of the
Externí odkaz:
https://doaj.org/article/afb495ca257e4a7d93148e83fe67162f
Autor:
Alessandro Perrella, Filomena Fortinguerra, Andrea Pierantozzi, Nicolina Capoluongo, Novella Carannante, Andrea Lo Vecchio, Francesca Futura Bernardi, Francesco Trotta, Agnese Cangini
Publikováno v:
Antibiotics, Vol 12, Iss 1, p 168 (2023)
Antimicrobial resistance (AMR) represents a major issue in healthcare being correlated to global inappropriate use of antibiotics. The aim of this study was to compare the data on hospital antibiotic consumption in 2020–2021 with those related to 2
Externí odkaz:
https://doaj.org/article/ac09c887d30347fbbc77384cc49f8295
Publikováno v:
Recenti progressi in medicina. 113(9)
The direct delivery of medicines by public healthcare facilities (Local health authorities, hospitals) is being discussed in Italy: the article considers opportunities and drawbacks of the different options (delivery through health facilities or thro
Autor:
Simona, Zito, Andrea, Pierantozzi, Marco, Marinelli, Fabio, Ambrosino, Francesco, Trotta, Agnese, Cangini
Publikováno v:
Recenti progressi in medicina. 113(2)
The "National Report on Medicines use in older adults in Italy. Year 2019" provides a summary of data concerning the expenditure and consumption of medicines in individuals aged 65 or above in Italy. In addition to general characteristics and conside
Autor:
Agnese Cangini, Maren Koban, Leonor Varela Lema, Spiros Vamvakas, Deborah Morrison, Sonia Garcia, Solange Corriol-Rohou, Emmanuel Gimenez Garcia, Anders Viberg, Piia Rannanheimo, Muriel Pasté, Alison Cave, Catherine Cohet, Peter Arlett, Xavier Kurz, Susan Sandler, Mercè Obach, Amr Makady, Hanna-Mari Jauhonen, Michael Berntgen, Virginia Acha, Emma Du Four, Jane Moseley, Karin Van Baelen, Chantal Guilhaume, Anja Langeneckert, Anna Strömgren, Marc Van De Casteele, Christelle Lamoril, Simon Bennett
Publikováno v:
British Journal of Clinical Pharmacology
The understanding of the benefit risk profile, and relative effectiveness of a new medicinal product, are initially established in a circumscribed patient population through clinical trials. There may be uncertainties associated with the new medicina
Publikováno v:
Health Policy and Technology. 9:32-38
Introduction In a context of financial constraints, an appropriate and efficient resource allocation represents the main issue of health care governance at any level of health decision-making processes. In these circumstances continuously monitoring